These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 34515130)

  • 21. Delivering therapeutic cannabinoids via skin: Current state and future perspectives.
    Tijani AO; Thakur D; Mishra D; Frempong D; Chukwunyere UI; Puri A
    J Control Release; 2021 Jun; 334():427-451. PubMed ID: 33964365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effectiveness of cannabinoids in the management of chronic nonmalignant neuropathic pain: a systematic review.
    Boychuk DG; Goddard G; Mauro G; Orellana MF
    J Oral Facial Pain Headache; 2015; 29(1):7-14. PubMed ID: 25635955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The legal status of cannabis (marijuana) and cannabidiol (CBD) under U.S. law.
    Mead A
    Epilepsy Behav; 2017 May; 70(Pt B):288-291. PubMed ID: 28169144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical cannabis and cannabinoids in rheumatology: where are we now?
    Sarzi-Puttini P; Batticciotto A; Atzeni F; Bazzichi L; Di Franco M; Salaffi F; Marotto D; Ceribelli A; Ablin JN; Hauser W
    Expert Rev Clin Immunol; 2019 Oct; 15(10):1019-1032. PubMed ID: 31512536
    [No Abstract]   [Full Text] [Related]  

  • 25. Co-exposure of cocaine and cannabinoids and its association with select biological, behavioural and health outcomes: A systematic scoping review of multi-disciplinary studies.
    Daldegan-Bueno D; Maia LO; Glass M; Jutras-Aswad D; Fischer B
    Eur Neuropsychopharmacol; 2021 Oct; 51():106-131. PubMed ID: 34273801
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Therapeutic Potential for Cannabinoids in Sports Medicine: Current Literature Review.
    Naik H; Trojian TH
    Curr Sports Med Rep; 2021 Jul; 20(7):345-350. PubMed ID: 34234089
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science.
    Baron EP
    Headache; 2018 Jul; 58(7):1139-1186. PubMed ID: 30152161
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extensive phytocannabinoid profiles of seized cannabis and cannabis-based medicines - Identification of potential distinguishing markers.
    Scheunemann A; Elsner K; Germerott T; Hess C; Zörntlein S; Röhrich J
    Forensic Sci Int; 2021 May; 322():110773. PubMed ID: 33839545
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Urinary cannabinoid mass spectrometry profiles differentiate dronabinol from cannabis use.
    Koch CD; Xu L; Curtis SA; Roberts JD; Bunch DR; El-Khoury JM
    Clin Chim Acta; 2020 Nov; 510():515-521. PubMed ID: 32795544
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Use of Cannabinoids for Insomnia in Daily Life: Naturalistic Study.
    Kuhathasan N; Minuzzi L; MacKillop J; Frey BN
    J Med Internet Res; 2021 Oct; 23(10):e25730. PubMed ID: 34704957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomised controlled trial of vaporised Δ
    Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
    Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
    Legare CA; Raup-Konsavage WM; Vrana KE
    Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabis and epilepsy: An ancient treatment returns to the fore.
    Russo EB
    Epilepsy Behav; 2017 May; 70(Pt B):292-297. PubMed ID: 27989385
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoids, hippocampal excitability and efficacy for the treatment of epilepsy.
    Yao I; Stein ES; Maggio N
    Pharmacol Ther; 2019 Oct; 202():32-39. PubMed ID: 31176695
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of cannabinoids for the treatment of patients with post-traumatic stress disorder.
    Forsythe ML; Boileau AJ
    J Basic Clin Physiol Pharmacol; 2021 Mar; 33(2):121-132. PubMed ID: 33662194
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cannabis, Cannabinoids, and Sleep: a Review of the Literature.
    Babson KA; Sottile J; Morabito D
    Curr Psychiatry Rep; 2017 Apr; 19(4):23. PubMed ID: 28349316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medical use of cannabis. Cannabidiol: a new light for schizophrenia?
    Deiana S
    Drug Test Anal; 2013 Jan; 5(1):46-51. PubMed ID: 23109356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain.
    Iskedjian M; Bereza B; Gordon A; Piwko C; Einarson TR
    Curr Med Res Opin; 2007 Jan; 23(1):17-24. PubMed ID: 17257464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Knowledge of Tetrahydrocannabinol and Cannabidiol Levels Among Cannabis Consumers in the United States and Canada.
    Hammond D; Goodman S
    Cannabis Cannabinoid Res; 2022 Jun; 7(3):345-354. PubMed ID: 33998866
    [No Abstract]   [Full Text] [Related]  

  • 40. A perspective on cannabinoids for treating epilepsy: Do they really change the landscape?
    Cross JH; Cock H
    Neuropharmacology; 2020 Jun; 170():107861. PubMed ID: 31770546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.